PAYER BARRIERS LIMIT TIMELY ACCESS Authored by Aurinia Pharma U.S., Inc. Timely access to therapy can be difficult to achieve....
The SAPHNELO Policy Acumen Portal provides up-to-date resources for billing, coding, and coverage policies specific to preselected payers. The link...
Deciding to start a blog comes with many questions and requires a lot of thought. During this process, one of...
Access Full Article from Reuters - Here
UPDATE! New Permanent J Code for SAPHNELO (anifrolumab-fnia) injection, for intravenous use, 300 mg/2mL The Centers for Medicare and Medicaid...
Wait times are a small part of each patient’s overall experience but can be a significant concern the longer they...
Authored by Aurinia Pharma U.S., Inc.Lupus nephritis (LN), a common and serious complication of systemic lupus erythematosus (SLE), occurs when...
This article on ASP recalculation for self-admin drugs will give you an understanding of how and why this change came...
New BlueCross program could change infusion billing as we know it A new program being touted by BlueCrossBlueShield of Tennessee...
We know your patients have questions, and you probably do too. That's why we worked with Aimed Alliance to develop...